Inovio Pharmaceuticals (INO)
(Delayed Data from NSDQ)
$6.69 USD
-0.08 (-1.18%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $6.68 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Inovio Pharmaceuticals, Inc. [INO]
Reports for Purchase
Showing records 101 - 120 ( 366 total )
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Coronavirus Crisis Update- Infections Moving West
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
32nd Annual Conference: Jonathan Aschoff''s Biotechnology Track Overview
Provider: Roth Capital Partners, Inc.
Analyst: ASCHOFF J
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Escalating Coronavirus Outbreaks Necessitate Fast-to-Market Vaccines; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
FDA Authorizes New INO-3107 Clinical Study; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Tracking the Course of the Coronavirus Epidemic: KOL Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Recurrent Respiratory Papillomatosis Pilot Data Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Conclusions from Our Coronavirus Call with Expert Dr. David Weiner, Ph.D.
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Chinese Collaboration Against New Coronavirus Established; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Beijing Advaccine Partnership To Advance New Coronavirus INO-4800 In China
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Expert Call - Potential Threats from the New Chinese Coronavirus
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Development of Vaccine Against New Coronavirus Funded; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
New Coronavirus Leads CEPI to Grant INO Up to $9M for Vaccine Development
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Inovio Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department